See more : Saudi Marketing Company (4006.SR) Income Statement Analysis – Financial Results
Complete financial analysis of Perimeter Medical Imaging AI, Inc. (PYNKF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Perimeter Medical Imaging AI, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Unibap AB (publ) (UNIBAP.ST) Income Statement Analysis – Financial Results
- Universal Microelectronics Co., Ltd. (2413.TW) Income Statement Analysis – Financial Results
- GSE Systems, Inc. (GVP) Income Statement Analysis – Financial Results
- Redeia Corporación, S.A. (RED.MC) Income Statement Analysis – Financial Results
- Hosken Consolidated Investments Limited (HCI.JO) Income Statement Analysis – Financial Results
Perimeter Medical Imaging AI, Inc. (PYNKF)
About Perimeter Medical Imaging AI, Inc.
Perimeter Medical Imaging AI, Inc., a medical technology company, develops and commercializes advanced imaging tools that allow surgeons, radiologists, and pathologists to visualize microscopic tissue structures during a clinical procedure. The company offers an optical coherence tomography (OCT) imaging system provides clinicians with cross-sectional of tissues down to 2 mm dept. This OCT imaging system consists of S-series OCT, B-series OCT, and OCT imaging console. It also offers ImgAssist, an artificial intelligence technology that enhances the efficiency of image review and be an additional powerful tool when combined with Perimeter OCT to aid physicians with real-time margin visualization and assessment to improve surgical outcomes for patients and reducing the likelihood of needing additional surgeries. In addition, the company offers proprietary image library and consumable specimen containers to hospitals and cancer surgery centers. Perimeter Medical Imaging AI, Inc. was founded in 2013 and is headquartered in Toronto, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 403.53K | 132.77K | 11.34K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 197.11K | 32.14K | 6.30K | 47.57K | 51.84K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 206.42K | 100.63K | 5.04K | -47.57K | -51.84K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 51.15% | 75.79% | 44.45% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 6.83M | 5.48M | 4.50M | 468.31K | 643.35K | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.12M | 5.45M | 7.89M | 8.84M | 7.51M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 4.96M | 4.84M | 3.67M | 122.94K | 36.78K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 14.68M | 10.28M | 11.56M | 8.96M | 7.54M | 135.62K | 123.44K | 137.17K | 184.42K |
| Other Expenses | 0.00 | 463.68K | 3.57K | 629.17K | 376.57K | 20.42K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 21.51M | 16.22M | 16.06M | 10.06M | 8.56M | 115.20K | 123.44K | 137.17K | 184.42K |
| Cost & Expenses | 21.58M | 16.25M | 16.07M | 10.06M | 8.56M | 115.20K | 123.44K | 137.17K | 184.42K |
| Interest Income | 0.00 | 0.00 | 10.36K | 6.90K | 4.65K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 104.93K | 110.31K | 117.05K | 155.97K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 614.70K | 1.04M | 93.84K | 47.57K | 51.84K | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -13.28M | -11.72M | -15.95M | -6.11M | -7.01M | -115.20K | -123.44K | -137.17K | -184.42K |
| EBITDA Ratio | -3,290.15% | -11,539.44% | -140,655.44% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -20.73M | -16.12M | -16.05M | -11.67M | -13.02M | -115.20K | -123.44K | -137.17K | -184.42K |
| Operating Income Ratio | -5,137.06% | -12,142.65% | -141,482.69% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 1.79M | 6.22M | -3.86M | 2.13M | -2.22M | 820.86K | 1.70M | -4.70M | -107.31K |
| Income Before Tax | -18.94M | -9.91M | -16.65M | -7.89M | -10.34M | 705.67K | 1.58M | -4.83M | -291.73K |
| Income Before Tax Ratio | -4,694.58% | -7,461.33% | -146,802.18% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 2.00 | -6.32M | 110.31K | 117.05K | 155.97K | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -18.94M | -3.59M | -16.76M | -8.00M | -10.50M | 705.67K | 1.58M | -4.83M | -291.73K |
| Net Income Ratio | -4,694.58% | -2,700.97% | -147,774.66% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.29 | -0.06 | -0.38 | -0.29 | -0.82 | 0.05 | 0.12 | -0.36 | -0.02 |
| EPS Diluted | -0.29 | -0.06 | -0.38 | -0.29 | -0.82 | 0.05 | 0.12 | -0.36 | -0.02 |
| Weighted Avg Shares Out | 64.67M | 60.62M | 44.11M | 27.22M | 12.82M | 13.30M | 13.30M | 13.30M | 13.30M |
| Weighted Avg Shares Out (Dil) | 64.67M | 60.62M | 44.11M | 27.22M | 12.82M | 13.30M | 13.30M | 13.30M | 13.30M |
Perimeter Provides Update on Canada Postal Strike and Mailing of the Company's 2024 Annual General Meeting Materials
TORONTO and DALLAS , Dec. 3, 2024 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, wishes to notify shareholders that in case of disruption due to the ongoing...
Perimeter B-Series OCT with ImgAssist AI 2.0 Demonstrates Super-Superiority Compared to Standard-of-Care in Pivotal Clinical Trial
– Intraoperative margin assessment during BCS using Perimeter B-Series OCT with ImgAssist AI 2.0 enabled surgeons to more effectively address residual cancer at the surgical margin as compared to current standard methods – – Primary endpoint met with statistically significant reduction...
Perimeter Medical Imaging to Announce Topline Results from Pivotal Clinical Trial Evaluating B-Series OCT with ImgAssist AI in Breast-Conserving Surgeries on November 20th; Conference Call to Follow
TORONTO and DALLAS , Nov. 18, 2024 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, announced that it will report topline results from the pivotal study evaluating the use of...
Perimeter Medical Imaging AI, Inc. (PYNKF) Q3 2024 Earnings Call Transcript
Perimeter Medical Imaging AI, Inc. (OTCPK:PYNKF) Q3 2024 Earnings Conference Call November 14, 2024 5:00 PM ET Corporate Participants Stephen Kilmer - Investor Relations Adrian Mendes - Chief Executive Officer Sara Brien - Chief Financial Officer Sarah Butler - Vice...
Perimeter Medical Imaging AI Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Conference Call/Webcast Today at 5 pm ET TORONTO and DALLAS , Nov. 14, 2024 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today reported financial results for its third quarter...
Perimeter Medical Imaging AI to Report Third Quarter 2024 Financial Results and Host Conference Call on November 14, 2024
TORONTO and DALLAS , Nov. 8, 2024 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK)(OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, announced it will report its third quarter 2024 financial and operating results after market...
Perimeter Medical Imaging AI Announces Additional Closing of Non-Brokered Private Placement
TORONTO and DALLAS , Oct. 10, 2024 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, is pleased to announce the second and final closing (the "Second Closing") of...
Perimeter Announces Completion of Patient Enrollment in Pivotal Clinical Trial Evaluating OCT B-Series with ImgAssist AI in Breast-Conserving Surgeries
– Perimeter OCT B-Series is the first system designed to combine AI with optical coherence tomography for margin assessment, with the aim of reducing the unacceptably high reoperation rates associated with BCS – – Recent study1 published in the Annals...
Perimeter Medical Imaging AI Announces Closing of Non-Brokered Private Placement
TORONTO and DALLAS , Sept. 30, 2024 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, is pleased to announce the closing of its non-brokered private placement of common...
Perimeter Medical Imaging AI Announces Non-Brokered Private Placement
TORONTO and DALLAS , Sept. 10, 2024 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today announced that it is undertaking a non-brokered private placement of up to...
Source: https://incomestatements.info
Category: Stock Reports